Epidermal growth factor receptor (EGFR)-mediated adverse events (AEs) in patients (pts) with EGFR mutation positive (EGFR M plus ) non-small cell lung cancer treated with afatinib
Resource
Eur. J. Cancer, 49, S190-S190
Journal
Eur. J. Cancer
Journal Issue
49
Pages
-
Date Issued
2013
Date
2013
Author(s)
Yang, J. Chih-Hsin
Sequist, L.
O'Byrne, K.
Schuler, M.
Mok, T.
Geater, S.
Massey, D.
O'Brien, D.
Zazulina, V.
Wu, Y. L.
SDGs